Denosumab Effective for Refractory Hypercalcemia of MalignancyDenosumab Effective for Refractory Hypercalcemia of Malignancy

Denosumab appears to reduce hypercalcemia of malignancy (HCM) that doesn't resolve with bisphosphonates, according to a planned interim analysis of an ongoing open-label proof of concept study. Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news